feed,title,long_url,short_url
Investors,Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near,https://www.investors.com/news/technology/biogen-stock-rises-on-the-fda-uncontroversial-take-on-alzheimers-treatment/,https://da.gd/g95W
